(redirected from Pneumococcal polysaccharide vaccine)
Also found in: Thesaurus, Medical, Acronyms, Wikipedia.
Related to Pneumococcal polysaccharide vaccine: pneumococcal vaccine, Pneumococcal conjugate vaccine
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Pneumovax - vaccine (trade name Pneumovax) effective against the 23 most common strains of pneumococcus
vaccine, vaccinum - immunogen consisting of a suspension of weakened or dead pathogenic cells injected in order to stimulate the production of antibodies
brand, brand name, marque, trade name - a name given to a product or service
References in periodicals archive ?
Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate caccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis.
2014) Use of 13-valent pneumococcal conjugate vaccines and 23-valent pneumococcal polysaccharide vaccine among adults aged's 65 years: recommendations of the Advisory Committee on Immunisation Practices.
The ACIP recommendation calls for pneumococcal vaccine-naive adults aged 65 and older to receive one dose of 13-valent pneumococcal conjugate vaccine (PCV13), followed by a dose of 23-valent pneumococcal polysaccharide vaccine (PPSV23) 6-12 months later (MMWR 2014:63;822-5).
Effectiveness when given less than 5 years after a pneumococcal polysaccharide vaccine is not known
Pneumococcal polysaccharide vaccine efficacy: An evaluation of current recommendations.
Starting August 5, the seasonal influenza and pneumococcal polysaccharide vaccines will be available at all 32 primary healthcare centres of Seha's Ambulatory Healthcare Services (AHS).
Recommendations of the Immunization Practices Advisory Committee Pneumococcal Polysaccharide Vaccine.
The pneumococcal polysaccharide vaccine protects against 23 types of pneumococcal bacteria.
Revaccination with pneumococcal polysaccharide vaccine is indicated after 5 years for certain medical conditions (ACIP, 2003).
Those who have chronic illness associated with pneumococcal disease should receive the pneumococcal polysaccharide vaccine.
Persons greater than or equal to 65 years old and all adults with medical conditions that place them at risk for pneumococcal disease or serious complications of influenza should receive one dose of pneumococcal polysaccharide vaccine and annual injections of influenza vaccine.

Full browser ?